The 36-month beta value for INSP is at 1.37. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 3 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for INSP is 29.66M, and currently, shorts hold a 7.80% of that float. The average trading volume for INSP on April 26, 2024 was 500.30K shares.
INSP) stock’s latest price update
Inspire Medical Systems Inc (NYSE: INSP) has seen a rise in its stock price by 3.80 in relation to its previous close of 231.01. However, the company has experienced a 4.61% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-18 that Inspire Medical’s (INSP) focus on R&D raises optimism about the stock.
INSP’s Market Performance
Inspire Medical Systems Inc (INSP) has experienced a 4.61% rise in stock performance for the past week, with a 12.32% rise in the past month, and a 12.68% rise in the past quarter. The volatility ratio for the week is 4.24%, and the volatility levels for the past 30 days are at 4.88% for INSP. The simple moving average for the past 20 days is 5.82% for INSP’s stock, with a 18.44% simple moving average for the past 200 days.
Analysts’ Opinion of INSP
Many brokerage firms have already submitted their reports for INSP stocks, with RBC Capital Mkts repeating the rating for INSP by listing it as a “Outperform.” The predicted price for INSP in the upcoming period, according to RBC Capital Mkts is $285 based on the research report published on April 19, 2024 of the current year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see INSP reach a price target of $250. The rating they have provided for INSP stocks is “Overweight” according to the report published on March 19th, 2024.
KeyBanc Capital Markets gave a rating of “Overweight” to INSP, setting the target price at $278 in the report published on February 06th of the current year.
INSP Trading at 16.30% from the 50-Day Moving Average
After a stumble in the market that brought INSP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.33% of loss for the given period.
Volatility was left at 4.88%, however, over the last 30 days, the volatility rate increased by 4.24%, as shares surge +11.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +24.64% upper at present.
During the last 5 trading sessions, INSP rose by +4.35%, which changed the moving average for the period of 200-days by -24.76% in comparison to the 20-day moving average, which settled at $227.83. In addition, Inspire Medical Systems Inc saw 17.88% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INSP starting from Buchholz Richard, who sale 15,000 shares at the price of $230.03 back on Apr 17 ’24. After this action, Buchholz Richard now owns 28,271 shares of Inspire Medical Systems Inc, valued at $3,450,450 using the latest closing price.
Herbert Timothy P., the CEO and President of Inspire Medical Systems Inc, sale 40,000 shares at $205.09 during a trade that took place back on Apr 01 ’24, which means that Herbert Timothy P. is holding 63,658 shares at $8,203,581 based on the most recent closing price.
Stock Fundamentals for INSP
Current profitability levels for the company are sitting at:
- -0.06 for the present operating margin
- 0.85 for the gross margin
The net margin for Inspire Medical Systems Inc stands at -0.03. The total capital return value is set at -0.07. Equity return is now at value -3.96, with -3.41 for asset returns.
Based on Inspire Medical Systems Inc (INSP), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at 0.99. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is 9.39.
Currently, EBITDA for the company is -40.27 million with net debt to EBITDA at 6.71. When we switch over and look at the enterprise to sales, we see a ratio of 11.37. The receivables turnover for the company is 6.95for trailing twelve months and the total asset turnover is 0.92. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.60.
Conclusion
In conclusion, Inspire Medical Systems Inc (INSP) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
